Gilead Sciences, Inc. (BCBA:GILD)

Gilead Sciences Revenue

In the year 2025, Gilead Sciences had annual revenue of $29.44B USD with 2.40% growth. Gilead Sciences had revenue of $7.93B in the quarter ending December 31, 2025, with 4.70% growth.

• Revenue: $29.44B
• Revenue Growth: +2.40%
• P/S Ratio: 6.73
• Revenue / Employee: $1.67M
• Employees: 17,600
• Market Cap: 268.11T ARS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	29.44B	689.00M	2.40%
Dec 31, 2024	28.75B	1.64B	6.04%
Dec 31, 2023	27.12B	-165.00M	-0.60%
Dec 31, 2022	27.28B	-24.00M	-0.09%
Dec 31, 2021	27.31B	2.62B	10.60%
Dec 31, 2020	24.69B	2.24B	9.98%
Dec 31, 2019	22.45B	322.00M	1.46%
Dec 31, 2018	22.13B	-3.98B	-15.24%
Dec 31, 2017	26.11B	-4.28B	-14.09%
Dec 31, 2016	30.39B	-2.25B	-6.89%
Dec 31, 2015	32.64B	7.75B	31.13%
Dec 31, 2014	24.89B	13.69B	122.19%
Dec 31, 2013	11.20B	1.50B	15.46%
Dec 31, 2012	9.70B	1.32B	15.70%
Dec 31, 2011	8.39B	435.97M	5.48%
Dec 31, 2010	7.95B	938.04M	13.38%
Dec 31, 2009	7.01B	1.68B	31.40%
Dec 31, 2008	5.34B	1.11B	26.14%
Dec 31, 2007	4.23B	1.20B	39.78%
Dec 31, 2006	3.03B	997.74M	49.19%
Dec 31, 2005	2.03B	-	-